EmendoBio: AnGes'. $250 Million Acquisition of EmendoBio
Morgan, Lewis & Bockius LLP represented EmendoBio in the transaction. AnGes, Inc., a commercial stage Japanese biopharmaceutical company focused on gene-based medicines, completed the acquisition of [...]
Read full article »
Emendo is a biotechnology company that develops and commercializes gene-editing therapeutics for the treatment of genetic diseases.
Read more